comparemela.com

Latest Breaking News On - சிவப்பு ஆய்வகங்கள் லிமிடெட் - Page 33 : comparemela.com

Govt slashes Remdesivir MRP by half, with retro-effect

Govt slashes Remdesivir MRP by half, with retro-effect ​ Sat, Apr 17 2021 12:51 IST | ​ 3 Views   Mumbai, April 17 : Spelling huge relief for lakhs of Covid-19 patients, the government has slashed the prices of the life-saver Remdesivir injection by nearly 50 per cent, to MRP Rs 2,450 per injection now, according to official sources. In a missive late on Friday, the Ministry of Chemicals & Fertilisers, Department of Pharmaceuticals, NPPA - Advisor (Costs) N.I. Chowdhury has ordered all pharma companies to comply with the revised norms with immediate and retrospective effect. Based on the Form-V furnished regarding voluntary reduction in Maximum Retail Price (MRP) of Remdesivir, Manufacturers/Marketers of the Remdesivir are hereby directed to implement the revised MRP throughout the distribution chain w.e.f. 15.04.2021, irrespective of the batch numbers, the stern notification said.

Govt slashes Remdesivir price by half to Rs 2,450 with retro-effect

Spelling huge relief for lakhs of Covid-19 patients, the government has slashed the prices of the life-saver Remdesivir injection by nearly 50 per cent, to MRP Rs 2,450 per injection now, according to official sources. In a missive late on Friday, the Ministry of Chemicals & Fertilisers, Department of Pharmaceuticals, NPPA - Advisor (Costs) N.I. Chowdhury has ordered all pharma companies to comply with the revised norms with immediate and retrospective effect. Based on the Form-V furnished regarding voluntary reduction in Maximum Retail Price (MRP) of Remdesivir, Manufacturers/Marketers of the Remdesivir are hereby directed to implement the revised MRP throughout the distribution chain w.e.f. 15.04.2021, irrespective of the batch numbers, the stern notification said.

Welcome To IANS Live - NATION - Dr Reddy s Laboratories gets authorisation for Sputnik V in India

Photo Credit: IANS IANSLive New Delhi, April 13 (IANS) Dr. Reddy s Laboratories Ltd. has announced that it has received the permission from the Drug Controller General of India (DCGI) to import the Sputnik vaccine into India for restricted use in emergency situations. To get full access of the story, click here to subscribe to IANS News Service © 2021 IANS India Private Limited. All Rights Reserved. The reproduction of the story/photograph in any form will be liable for legal action. For news, views and gossips, follow IANS at Twitter. Update: 13-April-2021

India s Dr Reddy s Laboratories Gets Permission to Import Russia s Sputnik Vaccine

To improve the performance of our website, show the most relevant news products and targeted advertising, we collect technical impersonal information about you, including through the tools of our partners. You can find a detailed description of how we use your data in our Privacy Policy. For a detailed description of the technologies, please see the Cookie and Automatic Logging Policy. By clicking on the Accept & Close button, you provide your explicit consent to the processing of your data to achieve the above goal. You can withdraw your consent using the method specified in the Privacy Policy. Accept & Close Sputnik International

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.